AG-024322
N-[[5-[3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]methyl]ethanamine
Molecular Identity
AG-024322
N-[[5-[3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]methyl]ethanamine
PubChem CID: 135413565
2D Structure
Properties
C23H20F2N6
Molecular Formula
418.40
Molecular Weight
g/mol
418.1718
Exact Mass
Da
3.7
XLogP
Drug-like (Lipinski: < 5)
82.3
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
6
H-Bond Acceptors
611
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
AG-024322837364-57-5AG-24322926F8X7TNO3-Pyridinemethanamine, 5-(3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl)-N-ethyl-4-methyl-AG 024322AG024322RefChem:110074CDK1/2/4 INHIBITOR AG-024322((5-(3-(4,6-difluoro-1H-1,3-benzodiazol-2-yl)-1H-indazol-5-yl)-4-methylpyridin-3-yl)methyl)(ethyl)amineCHEMBL4589128N-((5-((19E)-3-(4,6-DIFLUORO-2H-BENZO[D]IMIDAZOL-2-YLIDENE)-2,3-DIHYDRO-1H-INDAZOL-5-YL)-4-METHYLPYRIDIN-3-YL)METHYL)ETHANAMINEUNII-926F8X7TNOAG 24322orb1707710
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to AG-024322
Loading drug network...